Location: New York NY, Montreal, Salt Lake City UT, Seattle WA,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18 - 70+
Code: NCT07304154
Phase1, Recruiting
Interested in new multiple sclerosis trials?
Get alerts for new trials in your area by subscribing now
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
for
Multiple Sclerosis
Location: New York NY, Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 60
Code: NCT07497399
Phase2, Recruiting
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
for
Multiple Sclerosis
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 70+
Code: NCT02659956
Recruiting
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
for
Multiple Sclerosis
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07115017
Recruiting
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
for
Multiple Sclerosis, Depression
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 65
Code: NCT06901687
Phase2, Recruiting
Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
for
Multiple Sclerosis, Hypertension
Location: Boston MA
Sponsor: University of Massachusetts, Boston
Sex: All
Age: 18+
Code: NCT06554340
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase2, Recruiting
Deciphering Preserved Autonomic Function After Multiple Sclerosis
for
Multiple Sclerosis, Control Subjects, Autonomic Dysreflexia
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 50
Code: NCT07012135
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.